Previous Article | Next Article ![]()
Infect. Immun., Nov 1995, 4307-4311, Vol 63, No. 11
KW Lee, A Thakur, AM Karim and PT LoVerde
A cDNA clone encoding Schistosoma mansoni phosphoglycerate kinase (SmPGK)
was previously identified by affinity-purified antibodies which are
specific for 3-h-old schistosomula tegumental antigens. Antibodies to the
recombinant SmPGK which has enzymatic activity were localized to various
tissues including the tegument of the 3-h-old schistosomula and 42-day-old
adult worms. In this study, we show that SmPGK is an immunogenic molecule
in both natural infection in humans and experimental vaccination in
animals. To understand the role that a highly conserved molecule like SmPGK
played during schistosome infection, we affinity purified antibodies to
SmPGK from patients with chronic schistosomiasis and demonstrated that they
did not cross-react with human PGK. However, affinity-purified rabbit
anti-SmPGK antibodies did show immunoreactivity to both human PGK and
rabbit PGK. Thus, during natural infection antibodies that cross-react with
human PGK are not produced; however, as a result of active immunization
with an intact conserved molecule, such cross-reacting antibodies are
produced. Immunological analysis of cyanogen bromide digests of SmPGK with
monoclonal antibodies that recognize SmPGK but not human PGK identifies a
B-cell epitope on a 12.2-kDa fragment represented by amino acids 61 to 174.
Copyright © 1995, American Society for Microbiology
Immune response to Schistosoma mansoni phosphoglycerate kinase during natural and experimental infection: identification of a schistosome- specific B-cell epitope
Department of Microbiology, State University of New York, Buffalo 14214, USA.
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»